Two Indian generics makers end battle to copy drugs amid patent debate

MUMBAI (Reuters) - Two Indian drugmakers said they had given up a battle to copy drugs developed by Bristol Myers Squibb and AstraZeneca, blaming a lack of government support for cheap generics and pressure from Big Pharma.

http://ift.tt/1XsWDxI

from Reuters: Health News
via animenewspro